Metabolites
Displaying metabolites 1526 - 1550 of 3755 in total
| Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
|---|---|---|---|---|---|
| ECMDB23073 | beta-D-Allofuranose | (2R,3R,4S,5R)-5-[(1R)-1,2-dihydroxyethyl]oxolane-2,3,4-triol | 180.1559 C6H12O6 |  | |
| ECMDB23065 | L-Tagatose-6-phosphate | {[(2S,3S,4R)-3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methoxy}phosphonic acid | Galactose metabolism PW000821 | 260.1358 C6H13O9P |  |
| ECMDB23064 | Alpha-D-glucose 6-phosphate | {[(2R,3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}phosphonic acid | 260.1358 C6H13O9P |  | |
| ECMDB23060 | Quinone 106-51-4 | cyclohexa-2,5-diene-1,4-dione | TCA cycle PW000779 More...TCA cycle (ubiquinol-10) PW001010 TCA cycle (ubiquinol-2) PW001002 TCA cycle (ubiquinol-3) PW001003 TCA cycle (ubiquinol-4) PW001004 TCA cycle (ubiquinol-5) PW001005 TCA cycle (ubiquinol-6) PW001006 TCA cycle (ubiquinol-7) PW001007 TCA cycle (ubiquinol-8) PW001008 TCA cycle (ubiquinol-9) PW001009 TCA cycle (ubiquinol-0) PW002023 | 108.0948 C6H4O2 |  |
| ECMDB23058 | 4-Oxohex-2-enedioate | 4-oxohex-2-enedioic acid | 158.1088 C6H6O5 |  | |
| ECMDB23055 | 4-methyl-5-(2-hydroxyethyl)thiazole 137-00-8 | 2-(4-methyl-1,3-thiazol-5-yl)ethan-1-ol | 143.207 C6H9NOS |  | |
| ECMDB23053 | 2-((2R,5Z)-2-Carboxy-4-methylthiazol-5(2H)-ylidene)ethyl phosphate | (5Z)-4-methyl-5-[2-(phosphonatooxy)ethylidene]-2,5-dihydro-1,3-thiazole-2-carboxylate | 264.172 C7H7NO6PS |  | |
| ECMDB23052 | (2R,3S)-2-Hydroxybutane-1,2,3-tricarboxylate | (1S,2R)-2-hydroxy-1-methylpropane-1,2,3-tricarboxylic acid | 206.1501 C7H10O7 |  | |
| ECMDB23051 | (2S,3S)-2-hydroxybutane-1,2,3-tricarboxylate | (1S,2S)-2-hydroxy-1-methylpropane-1,2,3-tricarboxylic acid | Propanoate metabolism PW000940 | 206.1501 C7H10O7 |  |
| ECMDB23049 | (2-amino-4-hydroxy-7,8-dihydropteridin-6-yl)methyl diphosphate | 6-({[hydroxy(phosphonooxy)phosphoryl]oxy}methyl)-2-imino-1,2,7,8-tetrahydropteridin-4-olate | Folate biosynthesis PW000908 | 352.1146 C7H8N5O8P2 |  |
| ECMDB23046 | N-Acetyl-5-glutamyl phosphate 15383-57-0 | 2-[(1-hydroxyethylidene)amino]-5-oxo-5-(phosphonooxy)pentanoic acid | 269.1458 C7H12NO8P |  | |
| ECMDB23042 | N-Acetyl-L-methionine 65-82-7 | 2-acetamido-4-(methylsulfanyl)butanoic acid | 191.248 C7H13NO3S |  | |
| ECMDB23041 | 5'-Phospho-ribosylglycinamide | {[(2R,3S,4R)-5-(2-aminoacetamido)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid | 286.1764 C7H15N2O8P |  | |
| ECMDB23038 | D-glycero-beta-D-manno-heptose 7-phosphate | [(2R)-2-hydroxy-2-[(2R,3S,4S,5S,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]ethoxy]phosphonic acid | Lipopolysaccharide biosynthesis PW000831 | 290.1618 C7H15O10P |  |
| ECMDB23032 | (E)-3-(Methoxycarbonyl)pent-2-enedioate | (2E)-3-(methoxycarbonyl)pent-2-enedioic acid | 188.1348 C7H8O6 |  | |
| ECMDB23030 | Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol | (2R)-4-{[(1S)-5-amino-1-{[(1S)-1-{[(1R)-1-carboxyethyl]-C-hydroxycarbonimidoyl}ethyl]-C-hydroxycarbonimidoyl}pentyl]-C-hydroxycarbonimidoyl}-2-{[(2S)-1-hydroxy-2-{[(2R)-1-hydroxy-2-{[(2R,3S,4R,5R,6R)-3-hydroxy-6-{[hydroxy({[hydroxy({[(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-yl]oxy})phosphoryl]oxy})phosphoryl]oxy}-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)oxan-4-yl]oxy}propylidene]amino}propylidene]amino}butanoic acid | 1673.0374 C86H143N7O21P2 |  | |
| ECMDB23028 | lipoate 62-46-4 | 5-(1,2-dithiolan-3-yl)pentanoic acid | Lipoic acid metabolism PW000770 | 206.326 C8H14O2S2 |  |
| ECMDB23026 | 2-(Formamido)-N(1)-(5-phospho-D-ribosyl)acetamidine 6157-85-3 | {[(2R,3S,4R)-3,4-dihydroxy-5-(2-formamidoethanimidamido)oxolan-2-yl]methoxy}phosphonic acid | 313.2017 C8H16N3O8P |  | |
| ECMDB23024 | GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol | (2R)-4-{[(1S)-5-amino-1-{[(1R)-1-{[(1R)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}pentyl]carbamoyl}-2-[(2S)-2-[(2R)-2-{[(2R,3R,4R,5S,6R)-3-acetamido-5-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-{[hydroxy({[hydroxy({[(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-yl]oxy})phosphoryl]oxy})phosphoryl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}propanamido]propanamido]butanoic acid | 1876.23 C94H156N8O26P2 |  | |
| ECMDB23023 | lipid II(A) | (4R)-N-[(1S,5R)-5-amino-5-carboxy-1-{[(1R)-1-{[(1R)-1-carboxyethyl]carboximidato}ethyl]-C-hydroxycarbonimidoyl}pentyl]-4-carboxy-4-{[(2S)-2-{[(2R)-2-{[(2R,3S,4R,5R,6R)-3-{[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(1-oxidoethylidene)amino]oxan-2-yl]oxy}-6-{[hydroxy({[hydroxy({[(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-yl]oxy})phosphoryl]oxy})phosphoryl]oxy}-2-(hydroxymethyl)-5-[(1-oxidoethylidene)amino]oxan-4-yl]oxy}-1-hydroxypropylidene]amino}-1-hydroxypropylidene]amino}butanecarboximidate | 1916.2077 C95H152N8O28P2 |  | |
| ECMDB23020 | 5-carboxyamino-1-(5-phospho-D-ribosyl)imidazole | {1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1H-imidazol-5-yl}carbamic acid | 339.1959 C9H14N3O9P |  | |
| ECMDB23016 | 5-amino-6-(D-ribitylamino)uracil | 5-amino-6-{[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]amino}-1,2,3,4-tetrahydropyrimidine-2,4-dione | 276.2465 C9H16N4O6 |  | |
| ECMDB23014 | 2,5-diamino-6-hydroxy-4-(5-phospho-D-ribosylamino)pyrimidine | 5-amino-6-{[(2R,3R,4S,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]amino}-2-imino-1,2-dihydropyrimidin-4-olate | 351.2099 C9H14N5O8P |  | |
| ECMDB23012 | 2(alpha-D-mannosyl)-3-phosphoglycerate | 3-(phosphonooxy)-2-{[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoic acid | 348.1978 C9H17O12P |  | |
| ECMDB23011 | 2-O-(6-Phospho-alpha-D-mannosyl)-D-glycerate | (2R)-3-hydroxy-2-{[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-2-yl]oxy}propanoic acid | 2-O-alpha-mannosyl-D-glycerate degradation PW002096 | 348.1978 C9H17O12P |  |